CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 884546
SAN FRANCISCO, CA
Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$111,450,793
+$28,172,378 QoQ
Shares Held
462,509
+5.0% QoQ
Ownership
0.712%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 643 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. JAZZ ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,450,793 | 462,509 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $83,278,415 | 440,510 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $72,129,300 | 424,290 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $61,614,259 | 467,483 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $54,659,759 | 515,075 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $76,441,265 | 615,717 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $75,800,918 | 615,517 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $59,237,811 | 531,710 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $52,204,097 | 489,123 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $55,386,456 | 459,944 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $62,195,442 | 505,654 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $66,529,312 | 513,978 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $57,928,205 | 467,276 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $65,356,831 | 446,640 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $67,336,672 | 422,677 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $53,566,585 | 401,880 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,717,567 | 357,141 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $53,974,836 | 346,726 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $42,550,708 | 333,993 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $41,479,437 | 318,558 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $57,398,326 | 323,116 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $46,907,253 | 285,376 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,783,549 | 277,392 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $38,751,399 | 271,768 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $39,541,111 | 358,357 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $48,360,135 | 484,862 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||